As of 2025-05-29, the EV/EBITDA ratio of Mithra Pharmaceuticals SA (MITRA.BR) is -2.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MITRA.BR's latest enterprise value is 211.34 mil EUR. MITRA.BR's TTM EBITDA according to its financial statements is -95.39 mil EUR. Dividing these 2 quantities gives us the above MITRA.BR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 9.4x | 5.2x |
| Forward P/E multiples | 4.7x - 12.2x | 5.6x |
| Fair Price | (9.64) - (16.34) | (10.61) |
| Upside | -4564.4% - -7666.5% | -5009.9% |
| Date | EV/EBITDA |